Know what’s really happening at
Triomics before you sign on.
- On the roadmap
- Healthcare AI
- Oncology
- Clinical Trials
Triomics is building a generative AI platform purpose-built for oncology, automating the complex work of matching cancer patients to clinical trials and abstracting data from unstructured medical records. With backing from top-tier investors and partnerships across NCI-designated cancer centers, the company sits at the intersection of two urgent needs: faster trial enrollment and better cancer care operations.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Triomics
- Monthly Record Processing
- 30k oncology medical records processed monthly
- Monthly Patient Screening
- 7, 000 patients screened monthly
- Trial Matching Accuracy
- >95% accuracy in trial matching
- Accrual Improvement
- >30% increase in trial accruals
- Screening Speed Improvement
- >70% faster eligibility screening
- Deployment Timeline
- 6 weeks rapid go-live
- Cancer Center Partnerships
- over 20 NCI-designated cancer centers
- Company Size
- 51-200
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- Healthcare AI landscape
- Healthcare AI growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Triomics TAM
- Healthcare AI market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Triomics do
- Triomics product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Triomics customers
- who uses Triomics
- Triomics ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Triomics competitors
- Triomics alternatives
- who competes with Triomics
- Triomics win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Triomics reviews
- Triomics NRR
- Triomics churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Triomics investment thesis
- Triomics moat
- bull case bear case
- Triomics risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Triomics ARR
- Triomics revenue
- Triomics valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Triomics founders
- Triomics CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
This profile is based on publicly available company data, funding records, and structured profile information.